Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Painsi Clemens |
** = Publikationen gelistet in SCI/SSCI/Pubmed
2024
Originalarbeit (Zeitschrift)
** Golob-Schwarzl, N; Pilic, J; Benezeder, T; Bordag, N; Painsi, C; Wolf, P
Eukaryotic Initiation Factor 4E (eIF4E) as a Target of Anti-Psoriatic Treatment.
J Invest Dermatol. 2024; 144(3):500-508.e3
Doi: 10.1016/j.jid.2022.12.028
Web of Science
PubMed
FullText
FullText_MUG
Korrektur
** Graier, T; Weger, W; Jonak, C; Sator, P; Zikeli, C; Prillinger, K; Sassmann, C; Gruber, B; Saxinger, W; Ratzinger, G; Painsi, C; Mlynek, A; Häring, N; Sadoghi, B; Trattner, H; Müllegger, R; Quehenberger, F; Salmhofer, W; Wolf, P
Author Correction: Real-world effectiveness of anti-interleukin-23 antibodies in chronic plaque-type psoriasis of patients from the Austrian Psoriasis Registry (PsoRA).
Sci Rep. 2024; 14(1): 7144
Doi: 10.1038/s41598-024-57807-3
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Pre-print
** Benezeder, T; Bordag, N; Woltsche, J; Teufelberger, A; Perchthaler, I; Weger, W; Salmhofer, W; Gruber-Wackernagel, A; Painsi, C; Zhan, Q; El-Heliebi, A; Babina, M; Clark, R; Wolf, P
Mast cells express IL17A, IL17F and RORC, are activated and persist with IL-17 production in resolved skin of patients with chronic plaque-type psoriasis.
Res Sq. 2024;
Doi: 10.21203/rs.3.rs-3958361/v1
[OPEN ACCESS]
PubMed
FullText
FullText_MUG
2023
Originalarbeit (Zeitschrift)
** Graier, T; Salmhofer, W; Jonak, C; Weger, W; Zikeli, C; Gruber, B; Sator, P; Prillinger, K; Mlynek, A; Schütz-Bergmayr, M; Richter, L; Ratzinger, G; Sassmann, C; Painsi, C; Häring, N; Wippel-Slupetzky, K; Skvara, H; Trattner, H; Inzinger, M; Bangert, C; Ellersdorfer, C; Falkensteiner, K; Sadoghi, B; Gruber-Wackernagel, A; Hofer, A; Legat, F; Lange-Asschenfeldt, B; Schmuth, M; Vujic, I; Hötzenecker, W; Saxinger, W; Müllegger, R; Quehenberger, F; Wolf, P
Entwicklung der Patientencharakteristika und der Wirksamkeit der Biologika-Therapie bei Patienten des Österreichischen Psoriasis-Registers von 2004 bis 2022.
J Dtsch Dermatol Ges. 2023; 21(12): 1513-1523.
Doi: 10.1111/ddg.15213_g
Web of Science
PubMed
FullText
FullText_MUG
** Graier, T; Salmhofer, W; Jonak, C; Weger, W; Zikeli, C; Gruber, B; Sator, P; Prillinger, K; Mlynek, A; Schütz-Bergmayr, M; Richter, L; Ratzinger, G; Sassmann, C; Painsi, C; Häring, N; Wippel-Slupetzky, K; Skvara, H; Trattner, H; Inzinger, M; Bangert, C; Ellersdorfer, C; Falkensteiner, K; Sadoghi, B; Gruber-Wackernagel, A; Hofer, A; Legat, F; Lange-Asschenfeldt, B; Schmuth, M; Vujic, I; Hötzenecker, W; Saxinger, W; Müllegger, R; Quehenberger, F; Wolf, P
Evolution of characteristics and biologic treatment effectiveness in patients of the Austrian psoriasis registry from 2004-2022.
J Dtsch Dermatol Ges. 2023; 21(12): 1513-1523.
Doi: 10.1111/ddg.15213
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Benezeder, T; Woltsche, J; Bordag, N; Teufelberger, A; Perchthaler, I; Weger, W; Gruber-Wackernagl, A; Salmhofer, W; Painsi, C; Pankratz, K; El-Heliebi, A; Babina, M; Clark, R; Wolf, P
Mast cells as potential drivers of inflammation in psoriasis
J INVEST DERMATOL. 2023; 143(11):S342-S342.-5th Inflammatory Skin Disease Summit (ISDS); NOV 15-18, 2023; Vienna, AUSTRIA.
[Poster]
Web of Science
** Golob-Schwarzl, N; Pilic, J; Vrebo, A; Reinprecht, C; Benezeder, T; Bordag, N; Painsi, C; Wolf, P
Bricilib - a new strategy for the treatment of psoriasis targeting eukaryotic translation initiation factor 4E
J INVEST DERMATOL. 2023; 143(11):S341-S341.-5th Inflammatory Skin Disease Summit (ISDS); NOV 15-18, 2023; Vienna, AUSTRIA.
[Poster]
Web of Science
2022
Abstract (Zeitschrift)
** Benezeder, T; Painsi, C; Zhan, Q; Clark, RA; Wolf, P
IL-17A+ mast cells in resolved psoriasis
J INVEST DERMATOL. 2022; 142(12):S242-S242.-51st Annual Meeting of the European-Society-for-Dermatological-Research (ESDR); SEP 28-OCT 01, 2022; Amsterdam, NETHERLANDS.
[Poster]
Web of Science
** Golob-Schwarzl, N; Pilic, J; Benezeder, T; Bordag, N; Painsi, C; Wolf, P
Eukaryotic translation initiation factor 4E (eIF4E) as a target of anti-psoriatic treatment
J INVEST DERMATOL. 2022; 142(12): S244-S244.
[Poster]
Web of Science
2021
Originalarbeit (Zeitschrift)
** Graier, T; Golob-Schwarzl, N; Weger, W; Benezeder, T; Painsi, C; Salmhofer, W; Wolf, P
Furin Expression in Patients With Psoriasis-A Patient Cohort Endangered to SARS-COV2?
Front Med (Lausanne). 2021; 8: 624462-624462.
Doi: 10.3389/fmed.2021.624462
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Graier, T; Salmhofer, W; Jonak, C; Weger, W; Kölli, C; Gruber, B; Sator, PG; Prillinger, K; Mlynek, A; Schütz-Bergmayr, M; Richter, L; Ratzinger, G; Painsi, C; Selhofer, S; Häring, N; Wippel-Slupetzky, K; Skvara, H; Trattner, H; Tanew, A; Inzinger, M; Tatarski, R; Bangert, C; Ellersdorfer, C; Lichem, R; Gruber-Wackernagel, A; Hofer, A; Legat, F; Schmiedberger, E; Strohal, R; Lange-Asschenfeldt, B; Schmuth, M; Vujic, I; Hoetzenecker, W; Trautinger, F; Saxinger, W; Müllegger, R; Quehenberger, F; Wolf, P
Biologic drug survival rates in the era of anti-interleukin-17 antibodies: a time-period-adjusted registry analysis.
Br J Dermatol. 2021; 184(6):1094-1105
Doi: 10.1111/bjd.19701
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Graier, T; Weger, W; Sator, PG; Salmhofer, W; Gruber, B; Jonak, C; Kölli, C; Schütz-Bergmayr, M; Vujic, I; Ratzinger, G; Häring, N; Painsi, C; Prillinger, K; Mlynek, A; Skvara, H; Trattner, H; Tanew, A; Lichem, R; Ellersdorfer, C; Legat, F; Gruber-Wackernagel, A; Hofer, A; Schmiedberger, E; Hoetzenecker, W; Müllegger, R; Saxinger, W; Quehenberger, F; Wolf, P
Effectiveness and clinical predictors of drug survival in psoriasis patients receiving apremilast: A registry analysis.
JAAD Int. 2021; 2: 62-75.
Doi: 10.1016/j.jdin.2020.10.012
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Sconocchia, T; Hochgerner, M; Schwarzenberger, E; Tam-Amersdorfer, C; Borek, I; Benezeder, T; Bauer, T; Zyulina, V; Painsi, C; Passegger, C; Wolf, P; Sibilia, M; Strobl, H
Bone morphogenetic protein signaling regulates skin inflammation via modulating dendritic cell function.
J Allergy Clin Immunol. 2021; 147(5):1810-1822
Doi: 10.1016/j.jaci.2020.09.038
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Kurzbericht/Letter
** Painsi, C; Schmid-Zalaudek, K; Weger, W; Hofmann-Wellenhof, R; Wolf, P; Lackner, HK; Fink-Puches, R; Inzinger, M; Gruber, B; Krenmayr, K; Mlynek, A; Ahlgrimm-Siess, V; Salmhofer, W
Teledermatological assessment of one psoriasis target lesion and patient-reported-PASI are sufficient for psoriasis monitoring.
J Dtsch Dermatol Ges. 2021; 19(7):1064-1066
Doi: 10.1111/ddg.14468
Web of Science
PubMed
FullText
FullText_MUG
** Painsi, C; Schmid-Zalaudek, K; Weger, W; Hofmann-Wellenhof, R; Wolf, P; Lackner, HK; Fink-Puches, R; Inzinger, M; Gruber, B; Krenmayr, K; Mlynek, A; Ahlgrimm-Siess, V; Salmhofer, W
Die Teledermatologische Beurteilung einer Psoriasis-Zielläsion und der vom Patienten selbst berechnete PASI sind suiffizient für das Psoriasis-Monitoring.
J Dtsch Dermatol Ges. 2021; 19(7):1064-1066
Doi: 10.1111/ddg.14468_g
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Golob-Schwarzl, N; Pilic, J; Benezeder, T; Painsi, C; Wolf, P
Eukaryotic Translation Initiation Factors (eIFs): Potential Therapeutic Targets in Psoriasis
J INVEST DERMATOL. 2021; 141(10): S177-S177.
[Poster]
Web of Science
** Golob-Schwarzl, N; Pilic, J; Benezeder, T; Painsi, C; Wolf, P
Eukaryotic Translation Initiation Factors (eIFs): Potential therapeutic targets in psoriasis
EXP DERMATOL. 2021; 30: 5-6.
[Oral Communication]
Web of Science
2020
Originalarbeit (Zeitschrift)
** Benezeder, T; Painsi, C; Patra, V; Dey, S; Holcmann, M; Lange-Asschenfeldt, B; Sibilia, M; Wolf, P
Dithranol targets keratinocytes, their crosstalk with neutrophils and inhibits the IL-36 inflammatory loop in psoriasis.
Elife. 2020; 9:
Doi: 10.7554/eLife.56991
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Borek, I; Köffel, R; Feichtinger, J; Spies, M; Glitzner-Zeis, E; Hochgerner, M; Sconocchia, T; Krump, C; Tam-Amersdorfer, C; Passegger, C; Benezeder, T; Tittes, J; Redl, A; Painsi, C; Thallinger, GG; Wolf, P; Stary, G; Sibilia, M; Strobl, H
BMP7 aberrantly induced in the psoriatic epidermis instructs inflammation-associated Langerhans cells.
J Allergy Clin Immunol. 2020; 145(4): 1194-1207.
Doi: 10.1016/j.jaci.2019.12.011
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2019
Originalarbeit (Zeitschrift)
** Painsi, C; Hesterberg, K; Lademann, J; Knorr, D; Patzelt, A; Vandersee, S; Meinke, MC; Richter, H; Bob, A; Knorr, F; Quehenberger, F; Lange-Asschenfeldt, B
Influence of Storage and Preservation Techniques on Egg-Derived Carotenoids: A Substantial Source for Cutaneous Antioxidants.
Skin Pharmacol Physiol. 2019; 32(2):65-71
Doi: 10.1159/000493147
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2018
Originalarbeit (Zeitschrift)
** Niederkorn, A; Frühauf, J; Schwantzer, G; Wutte, N; Painsi, C; Werner, S; Stradner, M; Berghold, A; Hermann, J; Aberer, E
CXCL13 is an activity marker for systemic, but not cutaneous lupus erythematosus: a longitudinal cohort study.
Arch Dermatol Res. 2018; 310(6):485-493
Doi: 10.1007/s00403-018-1836-6
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Wolf, P; Weger, W; Legat, F; Painsi, C; Saxinger, W; Müllegger, R; Sator, P; Ratzinger, G; Selhofer, S; Richter, L; Salmhofer, W; Lange-Asschenfeldt, B; Trautinger, F; Mlynek, A; Strohal, R; Augustin, M; Quehenberger, F
Quality of life and treatment goals in psoriasis from the patient perspective: results of an Austrian cross-sectional survey.
J Dtsch Dermatol Ges. 2018; 16(8):981-990
Doi: 10.1111/ddg.13613
Web of Science
PubMed
FullText
FullText_MUG
** Wolf, P; Weger, W; Legat, F; Painsi, C; Saxinger, W; Müllegger, R; Sator, P; Ratzinger, G; Selhofer, S; Richter, L; Salmhofer, W; Lange-Asschenfeldt, B; Trautinger, F; Mlynek, A; Strohal, R; Augustin, M; Quehenberger, F
Lebensqualität und Behandlungsziele bei Psoriasis aus Patientensicht: Ergebnisse eines österreichweiten Querschnitt-Survey.
J Dtsch Dermatol Ges. 2018; 16(8):981-991
Doi: 10.1111/ddg.13613_g
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Benezeder, T; Painsi, C; Lange-Asschenfeldt, B; Wolf, P
Dithranol in psoriasis: Keratinocyte-neutrophil crosstalk and TREM1 signaling
J INVEST DERMATOL. 2018; 138(5):S75-S75.-International Investigative Dermatology (IID) Meeting; MAY 16-19, 2018; Orlando, FL.
Doi: 10.1016/j.jid.2018.03.452
[Poster]
Web of Science
FullText
FullText_MUG
** Benezeder, T; Painsi, C; Patra, V; Schmidbauer, U; Lange-Asschenfeld, B; Wolf, P
Keratinocytes are the primary target of dithranol in psoriasis
EXP DERMATOL. 2018; 27: 12-12.-3rd Inflammatory Skin Disease Summit; DEC 12-15, 2018; Vienna, AUSTRIA.
[Poster]
Web of Science
2017
Originalarbeit (Zeitschrift)
** Painsi, C; Hirtenfelder, A; Lange-Asschenfeldt, B; Quehenberger, F; Wolf, P
The Prevalence of Periodontitis Is Increased in Psoriasis and Linked to Its Inverse Subtype.
Skin Pharmacol Physiol. 2017; 30(6):324-328
Doi: 10.1159/000481544
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Kurzbericht/Letter
** Painsi, C; Aubell, K; Wolf, P; Hügel, R; Lange-Asschenfeldt, B
A case of Schöpf-Schulz-Passarge syndrome caused by c.1135C>T WNT10A missense mutation.
J DTSCH DERMATOL GES. 2017; 15(4): 454-456.
Doi: 10.1111/ddg.13183_g
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Korrespondenz
** Hammer, K; Hügel, R; Lange-Asschenfeldt, B; Painsi, C
Image Gallery: Cutaneous signs of acute pancreatitis.
Br J Dermatol. 2017; 177(5): e222-e222.
Doi: 10.1111/bjd.15951
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Painsi, C; Lange-Asschenfeldt, B
Image Gallery: Pink papules within a tattoo linked to Mycobacterium chelonae infection.
Br J Dermatol. 2017; 177(1): e1-e1.
Doi: 10.1111/bjd.15481
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Benezeder, TH; Painsi, C; Lange-Asschenfeldt, B; Hammer, K; Wolf, P
Chemokine ligand 22 (CCL22) plasma levels correlate with disease severity and predict response to dithranol treatment in patients with psoriasis
J INVEST DERMATOL. 2017; 137(10):S200-S200.-47th Annual Meeting of the European-Society-for-Dermatological-Research (ESDR); SEP 27-30, 2017; Salzburg, AUSTRIA.
Doi: 10.1016/j.jid.2017.07.143
[Poster]
Web of Science
FullText
FullText_MUG
** Benezeder, TH; Painsi, C; Mayer, G; Schmidbauer, U; Hammer, K; Lange-Asschenfeld, B; Wolf, P
Dithranol in psoriasis: keratinocyte-neutrophil cross-talk as the early target
BRIT J DERMATOL. 2017; 177(5):E286-E286.-8th International Congress on Psoriasis Gene to Clinic; NOV 30-DEC 02, 2017; London, ENGLAND.
[Oral Communication]
Web of Science
** Painsi, C; Hirtenfelder, A; Lange-Asschenfeldt, B; Quehenberger, F; Wolf, P
The prevalence of periodontitis is increased in psoriasis and linked to its inverse subtype
J INVEST DERMATOL. 2017; 137(10):S198-S198.-47th Annual Meeting of the European-Society-for-Dermatological-Research (ESDR); SEP 27-30, 2017; Salzburg, AUSTRIA.
Doi: 10.1016/j.jid.2017.07.132
[Poster]
Web of Science
FullText
FullText_MUG
** Wolf, P; Weger, W; Richter, L; Mlynek, A; Sator, P; Saxinger, W; Ratzinger, G; Kolli, C; Painsi, C; Bangert, C; Tatarski, R; Schutz-Bergmayr, M; Ponholzer, P; Trautinger, F; Strohal, R; Mullegger, R; Inzinger, M; Lichem, R; Salmhofer, W; Quehenberger, F
Switching or restarting of tumour necrosis factor-alpha inhibitors after interruption under daily-life conditions: efficacy report from the Austrian Psoriasis Registry (PsoRA)
BRIT J DERMATOL. 2017; 177(5): E250-E250.
[Oral Communication]
Web of Science
2016
Originalarbeit (Zeitschrift)
** Hügel, R; Muendlein, A; Volbeding, L; Drexel, H; Richtig, E; Wehkamp, U; Painsi, C; Lange-Asschenfeldt, B; Hauschild, A; Egberts, F
Serum levels of hepatocyte growth factor as a potential tumor marker in patients with malignant melanoma.
Melanoma Res. 2016; 26(4):354-360
Doi: 10.1097/CMR.0000000000000269
Web of Science
PubMed
FullText
FullText_MUG
** Inzinger, M; Wippel-Slupetzky, K; Weger, W; Richter, L; Mlynek, A; Fleischander, B; Scheurecker, C; Sandor, N; Mairhofer, D; Sator, PG; Moser-Oberthaler, S; Häring, N; Viznerova, P; Painsi, C; Tanew, A; Ponholzer, P; Tatarski, R; Brenner, W; Stingl, G; Salmhofer, W; Rappersberger, K; Klein, G; Saxinger, W; Auböck, J; Kölli, C; Trautinger, F; Steiner, A; Ratzinger, G; Strohal, R; Riedl, E; Lange-Asschenfeldt, B; Pehamberger, H; Volc-Platzer, B; Selhofer, S; Legat, FJ; Müllegger, R; Reider, N; Schmuth, M; Hintner, H; Hofer, A; Gruber-Wackernagel, A; Aberer, W; Quehenberger, F; Wolf, P
Survival and Effectiveness of Tumour Necrosis Factor-alpha Inhibitors in the Treatment of Plaque Psoriasis under Daily Life Conditions: Report from the Psoriasis Registry Austria.
Acta Derm Venereol. 2016; 96(2):207-212
Doi: 10.2340/00015555-2214
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Krediet, JT; Kanitakis, J; Bob, A; Schmitter, J; Krediet, AC; Röwert, J; Stockfleth, E; Painsi, C; Hügel, R; Terhorst, D; Lange-Asschenfeldt, B
Prognostic value of the area and density of lymphatic vessels in cutaneous squamous cell carcinoma.
J Dtsch Dermatol Ges. 2016; 14(11): 1114-1121.
Doi: 10.1111/ddg.12880
Web of Science
PubMed
FullText
FullText_MUG
Kurzbericht/Letter
** Painsi, C; Huegel, R; Lange-Asschenfeldt, B
Herpes zoster in an infant without postnatal varicella infection].
J Dtsch Dermatol Ges. 2016; 14(4): 429-430.
Doi: 10.1111/ddg.12860
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
2015
Originalarbeit (Zeitschrift)
** Painsi, C; Patscheider, M; Inzinger, M; Lange-Asschenfeldt, B; Quehenberger, F; Wolf, P
Patient perspectives on treating psoriasis with classic inpatient dithranol therapy: a retrospective patient survey.
J Dtsch Dermatol Ges. 2015; 13(11):1156-1163
Doi: 10.1111/ddg.12820
Web of Science
PubMed
FullText
FullText_MUG
** Ulrich, C; Kluschke, F; Patzelt, A; Vandersee, S; Czaika, VA; Richter, H; Bob, A; Hutten, Jv; Painsi, C; Hüge, R; Kramer, A; Assadian, O; Lademann, J; Lange-Asschenfeldt, B
Clinical use of cold atmospheric pressure argon plasma in chronic leg ulcers: A pilot study.
J Wound Care. 2015; 24(5): 202- 203.
Doi: 10.12968/jowc.2015.24.5.196
Web of Science
PubMed
FullText
FullText_MUG
Kurzbericht/Letter
** Painsi, C; Patscheider, M; Inzinger, M; Huegel, R; Lange-Asschenfeldt, B; Quehenberger, F; Wolf, P
Psoriasis Area and Severity Index 75 rate of classical inpatient dithranol therapy under daily life conditions.
Br J Dermatol. 2015; 173(3):815-817
Doi: 10.1111/bjd.13744
Web of Science
PubMed
FullText
FullText_MUG
** Painsi, C; Tarmann, R; Georg Würtz, F; Malle, P; Wolf, P; Hügel, R; Lange-Asschenfeldt, B
Multiple miliary osteoma cutis of the scalp.
J Dtsch Dermatol Ges. 2015; 13(11): 1185-1187.
Doi: 10.1111/ddg.12836
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
2014
Originalarbeit (Zeitschrift)
** Bretterklieber, A; Painsi, C; Avian, A; Wutte, N; Aberer, E
Impaired quality of life in patients with systemic sclerosis compared to the general population and chronic dermatoses.
BMC Res Notes. 2014; 7(3):594-594
Doi: 10.1186/1756-0500-7-594
[OPEN ACCESS]
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Inzinger, M; Weger, W; Wippel-Slupetzky, K; Fleischanderl, B; Richter, L; Mlynek, A; Viznerova, P; Scheurecker, C; Sandor, N; Haring, N; Sator, P; Tatarski, R; Tanew, A; Painsi, C; Mairhofer, D; Moser-Oberthaler, S; Ponholzer, P; Brenner, W; Salmhofer, W; Stingl, G; Saxinger, W; Rappersberger, K; Klein, G; Riedl, E; Aubock, J; Kolli, C; Strohal, R; Steiner, A; Selhofer, S; Pehamberger, H; Lange-Asschenfeldt, B; Trautinger, F; Reider, N; Vloc-Platzer, B; Legat, FJ; Mullegger, R; Hintner, H; Ratzinger, G; Schmuth, M; Hofer, A; Gruber-Wackernagel, A; Aberer, W; Quehenberger, F; Wolf, P
Drug adherence to ustekinumab in the treatment of plaque psoriasis under daily life conditions: report from the Psoriasis Registry Austria
BRIT J DERMATOL. . 2014; 171(6):E168-E168.-7th International Congress of Psoriasis - From Gene to Clinic; DEC 11-13, 2014; London, ENGLAND.
[Poster]
Web of Science